Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA. - Wikidata - awgldk - TriplyDB

Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA.

Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA.

http://www.wikidata.org/entity/Q33831680

about

Regulatory systems in bone marrow for hematopoietic stem/progenitor cells mobilization and homing.Novel agents and approaches for stem cell mobilization in normal donors and patients.Current clinical indications for plerixafor A plerixafor-based strategy allows adequate hematopoietic stem cell collection in poor mobilizers: results from the Canadian Special Access Program.Stem cell mobilization in patients with dialysis-dependent multiple myeloma: Report of the Polish Myeloma Study Group.Plerixafor and G-CSF for autologous stem cell mobilization in AL amyloidosis.Unsuccessful stem cell remobilization for autologous transplantation is predicted by renal impairment and a stem cell yield ⩽0.5 × 106 CD34+ cells/kg at first mobilization

P2860

Q27692619-125B9E72-A429-4A4A-A817-23FE06EC246A Q37923309-88FEFA8D-EF15-4B7F-8388-113732B8FB01 Q38177784-42F7451A-0E26-4C89-83BF-089DECC1411E Q38194916-6CC03E5B-1C40-4794-A467-52AA73CCC27D Q47967442-17F5D394-F00F-4FB4-9831-D20B3D906D5B Q53041697-D2DF9FE6-98C4-49AC-8BD5-C75941D5E089 Q57655194-341022E1-2342-4B15-BD12-30D51BDE5739

P2860

Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA.

http://www.wikidata.org/entity/Q33831680

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Plerixafor for PBSC mobilisati ...... ients from Europe and the USA.

@ast

Plerixafor for PBSC mobilisati ...... ients from Europe and the USA.

@en

type

label

Plerixafor for PBSC mobilisati ...... ients from Europe and the USA.

@ast

Plerixafor for PBSC mobilisati ...... ients from Europe and the USA.

@en

prefLabel

Plerixafor for PBSC mobilisati ...... ients from Europe and the USA.

@ast

Plerixafor for PBSC mobilisati ...... ients from Europe and the USA.

@en

P1433

Q33831680-E082ABA7-33BA-40AA-893B-319EBF8D9060

P1476

Q33831680-E67B260C-65CB-47D1-9FB5-378619D105C2

P2093

Q33831680-149FE3C8-F847-4585-8C3C-F7FD4C668025

Q33831680-1910F6BB-C76F-49D9-ADCE-D87C4D3BD342

Q33831680-1DB8CEF2-1939-426F-BCFC-9CED8B4D1D6E

Q33831680-26E4C810-EA93-41D9-9127-6248AE10FEE2

Q33831680-513DB7E0-8096-47D7-93B0-54C936632838

Q33831680-59377A2D-F481-4377-9043-C675D27A6161

Q33831680-5948F071-5EE0-4897-91B4-DEE379327123

Q33831680-5CCEC102-2B9F-4188-A856-78CCE7F7FD49

Q33831680-70AB052E-0F3E-46AB-94CA-35B2CF43B166

Q33831680-956FA8F8-EA6F-48E6-A9D0-09FC0623EAB9

P2860

Q33831680-228AAC5B-BFC3-4CF3-84FC-E169CB127FCC

Q33831680-31A20618-9AA3-41A5-90D8-8DDFFAF879B7

Q33831680-4BBBB325-661B-4448-9916-BEBC17541C7B

Q33831680-58C78FC5-9A2A-4F76-9263-B9733C32AD61

Q33831680-5D2E0931-D825-45A5-93B0-F117DAC378A3

Q33831680-6123C48B-F0C5-4916-A647-9DB0C402248A

Q33831680-79DC7C09-C105-4BC7-B776-1F3292DBF3C4

Q33831680-829D233D-F614-4B93-849E-41082460455C

Q33831680-8CEDAB9D-FCF9-4D6D-A675-C36847C0FE40

Q33831680-BA33E0A3-E61E-48F4-8047-87B96CD228E2

P2888

Q33831680-2D212B11-66F0-446A-8216-17766A5634B3

P304

Q33831680-28D71352-C4E7-4F11-858D-48E84414A88F

P31

Q33831680-6A8CFF9E-DF23-41B0-AEDA-187CAEA12B67

P356

Q33831680-FF335A82-B338-40C3-BAD1-BD26F23FA139

P407

Q33831680-25AD2755-E8D5-4DED-867E-8609F24894E9

P433

Q33831680-435D1EC8-059F-4776-A012-D66075DEF004

P478

Q33831680-58D301ED-EAA0-4567-993F-201CE304ADD9

P577

Q33831680-7947F8C4-D9E0-40D6-BF13-0ED5BD065F18

P5875

Q33831680-AEF622F8-F0D4-4C48-8E8A-7B51294A7455

P6179

Q33831680-E359F02F-3490-4538-9891-7F9CEFCA4740

P698

Q33831680-59BC6AD3-9107-49FD-AA23-52526160A19D

P356

P1433

Bone Marrow Transplantation

P1476

Plerixafor for PBSC mobilisati ...... ients from Europe and the USA.

@en

P2093

A D'Addio

http://www.w3.org/2001/XMLSchema#string

A N Parker

http://www.w3.org/2001/XMLSchema#string

A Pagliuca

http://www.w3.org/2001/XMLSchema#string

A Rahemtulla

http://www.w3.org/2001/XMLSchema#string

C Scheid

http://www.w3.org/2001/XMLSchema#string

G Cook

http://www.w3.org/2001/XMLSchema#string

G Mikala

http://www.w3.org/2001/XMLSchema#string

J Treisman

http://www.w3.org/2001/XMLSchema#string

J Uberti

http://www.w3.org/2001/XMLSchema#string

K Rao

http://www.w3.org/2001/XMLSchema#string

P2860

AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data.

Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data.

Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers.

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.

Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens.

Meeting the unmet needs in anticoagulant therapy.

A pharmacokinetic study of plerixafor in subjects with varying degrees of renal impairment.

Myopericarditis caused by cyclophosphamide used to mobilize peripheral blood stem cells in a myeloma patient with renal failure.

Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant.

Autologous stem cell transplantation in multiple myeloma: outcome in patients with renal failure.

P2888

P304

18-23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2011.9

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50227767

http://www.w3.org/2001/XMLSchema#string

P6179

1035285626

http://www.w3.org/2001/XMLSchema#string

P698

21358693

http://www.w3.org/2001/XMLSchema#string